1420790-22-2 Usage
Uses
Used in Chemical Research:
8-bromo-7-fluoroquinoline is utilized as a research compound for studying the biological effects of quinolines. Its distinct structure allows scientists to investigate how modifications in the quinoline family influence various biological activities.
Used in Pharmaceutical Applications:
In the pharmaceutical industry, 8-bromo-7-fluoroquinoline serves as a starting material or intermediate in the development of new pharmaceutical compounds. Its antimicrobial and antifungal properties make it a promising candidate for the creation of novel drugs targeting infectious diseases.
Used in Antimicrobial Agents:
8-bromo-7-fluoroquinoline is employed as an antimicrobial agent, leveraging its ability to combat a range of microbial infections. Its effectiveness in this application is attributed to its unique chemical structure, which contributes to its bioactivity against various pathogens.
Used in Antifungal Agents:
Similarly, 8-bromo-7-fluoroquinoline is used as an antifungal agent, helping to treat and prevent fungal infections. Its incorporation into antifungal medications is due to its demonstrated capability to inhibit fungal growth and development.
Check Digit Verification of cas no
The CAS Registry Mumber 1420790-22-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,2,0,7,9 and 0 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1420790-22:
(9*1)+(8*4)+(7*2)+(6*0)+(5*7)+(4*9)+(3*0)+(2*2)+(1*2)=132
132 % 10 = 2
So 1420790-22-2 is a valid CAS Registry Number.
1420790-22-2Relevant academic research and scientific papers
5-HETEROARYL-PYRIDIN-2-AMINE CONFOUNDS AS NEUROPEPTIDE FF RECEPTOR ANTAGONISTS
-
Page/Page column 53; 62, (2021/02/12)
The present invention relates to novel aminopyridine derivatives of the general formula (I) and pharmaceutical compositions comprising these compounds, as well as their therapeutic use, particularly as neuropeptide FF (NPFF) receptor antagonists, including, e.g., for the treatment or prevention of pain, opioid-induced hyperalgesia, or addiction.
